Syngeneic adipose-derived stem cells with short-term immunosuppression induce vascularized composite allotransplantation tolerance in rats

Cytotherapy

Volumn 16, Issue 3, 2014, Pages 369-380

  Cheng, Hui Yun ^a,b   Ghetu, Nicolae ^a   Huang, Wei Chao ^c   Wang, Yen Ling ^a   Wallace, Christopher Glenn ^a   Wen, Chih Jen ^d   Chen, Hung Chang ^e   Shih, Ling Yi ^a   Lin, Chih Fan ^d   Hwang, Shiaw Min ^f   Liao, Shuen Kuei ^g,h   Wei, Fu Chan ^a,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Chang Gung Medical Foundation   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h Vectorite Biomedica Inc   (Taiwan)

Author keywords

Adipose derived stem cell; Allotransplantation; Regulatory T cell; Tolerance; Vascularized composite

Indexed keywords

ADIPOSE-DERIVED STEM CELL; ALLOTRANSPLANTATION; REGULATORY T CELL; TOLERANCE; VASCULARIZED COMPOSITE;

ANIMALS; CELLS, CULTURED; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED LEW; STEM CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

EID: 84895147809     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.06.020     Document Type: Article

References (55)

1. Siemionow M., Ozturk C. An update on facial transplantation cases performed between 2005 and 2010. Plast Reconstr Surg 2011, 128:707e-720e.
2. Shores J.T., Imbriglia J.E., Lee W.P. The current state of hand transplantation. JHand Surg Am 2011, 36:1862-1867.
3. Kaufman C.L., Breidenbach W. World experience after more than a decade of clinical hand transplantation: update from the Louisville hand transplant program. Hand Clin 2011, 27:417-421.
4. Lee W.P., Yaremchuk M.J., Pan Y.C., Randolph M.A., Tan C.M., Weiland A.J. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991, 87:401-411.
5. Schneeberger S., Landin L., Jableki J., Butler P., Hoehnke C., Brandacher G., et al. Achievements and challenges in composite tissue allotransplantation. Transpl Int 2011, 24:760-769.
6. Siemionow M. Impact of reconstructive transplantation on the future of plastic and reconstructive surgery. Clin Plast Surg 2012, 39:425-434.
7. Page E.K., Dar W.A., Knechtle S.J. Tolerogenic therapies in transplantation. Front Immunol 2012, 3:198.
8. Franquesa M., Hoogduijn M.J., Baan C.C. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance. Curr Opin Organ Transplant 2012, 17:355-361.
9. Cui L., Yin S., Liu W., Li N., Zhang W., Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007, 13:1185-1195.
10. Djouad F., Charbonnier L.M., Bouffi C., Louis-Plence P., Bony C., Apparailly F., et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007, 25:2025-2032.
11. Choi Y.S., Jeong J.A., Lim D.S. Mesenchymal stem cell-mediatedimmature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest 2012, 41:214-229.
12. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
13. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. JImmunol 2008, 181:3933-3946.
14. Ge W., Jiang J., Baroja M.L., Arp J., Zassoko R., Liu W., et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009, 9:1760-1772.
15. Ge W., Jiang J., Arp J., Liu W., Garcia B., Wang H. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 2010, 90:1312-1320.
16. Ito T., Itakura S., Todorov I., Rawson J., Asari S., Shintaku J., et al. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 2010, 89:1438-1445.
17. Sbano P., Cuccia A., Mazzanti B., Urbani S., Giusti B., Lapini I., et al. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Arch Dermatol Res 2008, 300:115-124.
18. Kuo Y.R., Goto S., Shih H.S., Wang F.S., Lin C.C., Wang C.T., et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 2009, 87:1769-1777.
19. Kuo Y.R., Chen C.C., Goto S., Huang Y.T., Wang C.T., Tsai C.C., et al. Immunomodulatory effects of bone marrow-derived mesenchymal stem cells in a swine hemi-facial allotransplantation model. PLoS One 2012, 7:e35459.
20. Izadpanah R., Trygg C., Patel B., Kriedt C., Dufour J., Gimble J.M., et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. JCell Biochem 2006, 99:1285-1297.
21. Kuo Y.R., Chen C.C., Goto S., Lee I.T., Huang C.W., Tsai C.C., et al. Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg 2011, 128:661e-672e.
22. Adamson L.A., Huang W.C., Breidenbach W.C., Rahhal D., Xu H., Huang Y., et al. Amodified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts. Microsurgery 2007, 27:630-636.
23. Zdichavsky M., Jones J.W., Ustuner E.T., Ren X., Edelstein J., Maldonado C., et al. Scoring of skin rejection in a swine composite tissue allograft model. JSurg Res 1999, 85:1-8.
24. Bunnell B.A., Flaat M., Gagliardi C., Patel B., Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008, 45:115-120.
25. Schaffler A., Buchler C. Concise review: adipose tissue-derived stromal cells: basic and clinical implications for novel cell-based therapies. Stem Cells 2007, 25:818-827.
26. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
27. Petruzzo P., Testelin S., Kanitakis J., Badet L., Lengele B., Girbon J.P., et al. First human face transplantation: 5 years outcomes. Transplantation 2012, 93:236-240.
28. Prabhune K.A., Gorantla V.S., Maldonado C., Perez-Abadia G., Barker J.H., Ildstad S.T. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery 2000, 20:441-447.
29. Wachtman G.S., Wimmers E.G., Gorantla V.S., Lin C.H., Schneeberger S., Unadkat J.V., et al. Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. Transplant Proc 2011, 43:3541-3544.
30. Gordon C.R., Tai C.Y., Suzuki H., Strande L.F., Ramsamooj R., Matthews M.S., et al. Review of vascularized bone marrow transplantation: current status and future clinical applications. Microsurgery 2007, 27:348-353.
31. Huang W.C., Liao S.K., Wallace C.G., Chang N.J., Lin J.Y., Wei F.C. Greater efficacy of tolerance induction with cyclosporine versus tacrolimus in composite tissue allotransplants with less myeloablative conditioning. Plast Reconstr Surg 2011, 127:1141-1148.
32. Engela A.U., Baan C.C., Dor F.J., Weimar W., Hoogduijn M.J. On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front Immunol 2012, 3:126.
33. + regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants. Transplantation 2011, 91:908-915.
34. Pilat N., Baranyi U., Klaus C., Jaeckel E., Mpofu N., Wrba F., et al. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant 2010, 10:751-762.
35. Lin J.Y., Tsai F.C., Wallace C.G., Huang W.C., Wei F.C., Liao S.K. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning. JSurg Res 2012, 178:974-981.
36. Eljaafari A., Badet L., Kanitakis J., Ferrand C., Farre A., Petruzzo P., et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation 2006, 82:1764-1768.
37. Graca L., Chen T.C., Le Moine A., Cobbold S.P., Howie D., Waldmann H. Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells. Trends Immunol 2005, 26:130-135.
38. Lin J.Y., Tsai F.C., Wallace C.G., Huang W.C., Wie F.C., Liao S.K. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning. Chimerism 2012, 4:20-22.
39. Yang H.M., Sung J.H., Choi Y.S., Lee H.J., Roh C.R., Kim J., et al. Enhancement of the immunosuppressive effect ofhuman adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression. Cytotherapy 2012, 14:70-79.
40. + regulatory T cells. Stem Cells 2008, 26:212-222.
41. Zarkhin V., Talisetti A., Li L., Wozniak L.J., McDiarmid S.V., Cox K., et al. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation 2010, 90:1000-1005.
42. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
43. Machado Cde V., Telles P.D., Nascimento I.L. Immunological characteristics of mesenchymal stem cells. Rev Bras Hematol Hemoter 2013, 35:62-67.
44. Kuo Y.R., Chen C.C., Shih H.S., Goto S., Huang C.W., Wang C.T., et al. Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model. Plast Reconstr Surg 2011, 127:569-579.
45. Griffin M.D., Ritter T., Mahon B.P. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010, 21:1641-1655.
46. Huang X.P., Sun Z., Miyagi Y., McDonald Kinkaid H., Zhang L., Weisel R.D., et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010, 122:2419-2429.
47. Beggs K.J., Lyubimov A., Borneman J.N., Bartholomew A., Moseley A., Dodds R., et al. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 2006, 15:711-721.
48. Poncelet A.J., Vercruysse J., Saliez A., Gianello P. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 2007, 83:783-790.
49. Gir P., Oni G., Brown S.A., Mojallal A., Rohrich R.J. Human adipose stem cells: current clinical applications. Plast Reconstr Surg 2012, 129:1277-1290.
50. Siemionow M., Madajka M., Cwykiel J. Application of cell-based therapies in facial transplantation. Ann Plast Surg 2012, 69:575-579.
51. Perico N., Casiraghi F., Introna M., Gotti E., Todeschini M., Cavinato R.A., et al. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol 2011, 6:412-422.
52. Eggenhofer E., Renner P., Soeder Y., Popp F.C., Hoogduijn M.J., Geissler E.K., et al. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model. Transpl Immunol 2011, 25:141-147.
53. Popp F.C., Eggenhofer E., Renner P., Slowik P., Lang S.A., Kaspar H., et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008, 20:55-60.
54. Chu Z., Zhang J., Zhao Y., Ji Q., Zhong J., Zhang C., et al. Influence of immunosuppressive drugs on the development of CD4(+)CD25(high) Foxp3(+) T cells in liver transplant recipients. Transplant Proc 2010, 42:2599-2601.
55. Lu L., Qian X.F., Rao J.H., Wang X.H., Zheng S.G., Zhang F. Rapamycin promotes the expansion of CD4(+) Foxp3(+) regulatory T cells after liver transplantation. Transplant Proc 2010, 42:1755-1757.